-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, N8Sxzo7P5XonFs9Ef0weUGNBDSGJtMxp/6SA0bJrqZoJH82dHinBZQSw2xXBYMIn cAZqeaFDkXMhYpYrKkAILA== 0000926372-96-000008.txt : 19960308 0000926372-96-000008.hdr.sgml : 19960308 ACCESSION NUMBER: 0000926372-96-000008 CONFORMED SUBMISSION TYPE: 10-C PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19960229 FILED AS OF DATE: 19960307 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: PUREPAC INC/ CENTRAL INDEX KEY: 0000729069 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042769995 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-C SEC ACT: 1934 Act SEC FILE NUMBER: 000-13588 FILM NUMBER: 96532299 BUSINESS ADDRESS: STREET 1: 200 ELMORA AVE CITY: ELIZABETH STATE: NJ ZIP: 07207 BUSINESS PHONE: 9085279100 MAIL ADDRESS: STREET 1: 200 ELMORA AVENUE STREET 2: 200 ELMORA AVENUE CITY: ELIZABETH STATE: NJ ZIP: 07207 FORMER COMPANY: FORMER CONFORMED NAME: MOLECULON INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: MOLECULON BIOTECH INC DATE OF NAME CHANGE: 19860417 10-C 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ---------------------- Form 10-C REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ INTERDEALER QUOTATION SYSTEM Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and Rule 13a-17 or 15d-17 thereunder Purepac, Inc. (Exact name of issuer as specified in charter) 200 Elmora Avenue, Elizabeth, New Jersey 07207 (Address of principal executive offices) (908) 527-9100 (Issuer's telephone number, including area code) 1. CHANGE IN NUMBER OF SHARES OUTSTANDING Indicate any change (increase or decrease) of 5% or more in the number of shares outstanding: 1. Title of security: Common Stock 2. Number of shares outstanding before the change: 12,581,223 3. Number of shares outstanding after the change: 15,091,539 4. Effective date of change: February 29, 1996 5. Method of change: Acquisition Specify method (such as merger, acquisition, exchange, distribution, stock split, reverse split, acquisition of stock for treasury, etc.) Give brief description of transaction: 2,510,316 shares of the Issuer's Common Stock were issued in exchange for all of the Common Stock of three corporations acquired by the Issuer. II. CHANGE IN NAME OF ISSUER 1. Name prior to change: Purepac, Inc. 2. Name after change: Faulding Inc. 3. Effective date of charter amendment changing name: February 29, 1996 4. Date of shareholder approval of change, if required: February 29, 1996 Date: March 7, 1996 /s/Richard F. Moldin -------------------- Richard F. Moldin President and Chief Executive Officer -----END PRIVACY-ENHANCED MESSAGE-----